Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAPATINIB vs LATANOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAPATINIB vs LATANOPROST: Safety Overview

Metric LAPATINIB LATANOPROST
Total FAERS Reports 1,983 15,362
Deaths Reported 267 309
Death Rate 13.5% 2.0%
Hospitalizations 498 873
Average Patient Age 54.1 yrs 71.9 yrs
% Female Patients 96.6% 65.9%
FDA Approval Date N/A Apr 14, 2025
Manufacturer N/A Thea Pharma Inc.
Route N/A OPHTHALMIC
Marketing Status N/A Prescription